| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/01/1998 | EP0850243A2 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 07/01/1998 | EP0850070A2 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| 07/01/1998 | EP0850064A1 Compositions with anti-apoptotic activity, containing a mixture of phospholipids |
| 07/01/1998 | EP0850063A1 Methods and compositions for treating fungal infections in mammals |
| 07/01/1998 | EP0850059A1 Pharmaceutical formulations containing darifenacin |
| 07/01/1998 | EP0850053A1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 07/01/1998 | EP0850051A2 Composition for sustained release of an agent |
| 07/01/1998 | EP0850049A1 Composition for ph dependent controlled release of active ingredients and methods for producing it |
| 07/01/1998 | EP0850048A2 Pharmaceutical granules |
| 07/01/1998 | EP0850046A2 Microemulsions for use as vehicles for administration of active compounds |
| 07/01/1998 | EP0814800A4 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 07/01/1998 | EP0665755B1 Preparation of pharmaceutical compositions containing a calcitonin |
| 07/01/1998 | EP0537165B1 Polymeric drug delivery system |
| 07/01/1998 | CN1186442A Methods for preparing monomeric calicheamicin derivative/carrier conjugates |
| 07/01/1998 | CN1186438A Methods and compositions for healing and repair of connective tissue attachment |
| 07/01/1998 | CN1186434A Pharmaceutical composition comprising proteinase inhibitor and monoglyceride |
| 07/01/1998 | CN1186431A Compositions and methods using nitroxides in combination with biocompatible macromolecules |
| 07/01/1998 | CN1186426A Dispersible particulate system for desensitizing teeth |
| 07/01/1998 | CN1186419A Apparatus and method for making gas-filled vesicles of optimal size |
| 07/01/1998 | CN1185945A Anti-cancer microballs and manufacture thereof |
| 07/01/1998 | CN1038904C Preparation of megestrol acetate |
| 06/30/1998 | US5773647 Using a aromatic compound containing amide and carboxy groups |
| 06/30/1998 | US5773608 Process for preparing stabilized chitin derivative compounds |
| 06/30/1998 | US5773586 Conjugates comprising truncated keratinocyte growth factor (KGF) having increased biological activity and a toxin |
| 06/30/1998 | US5773581 Acid stable substance dervived from naturally occuring granulocyte colony stimulating factor |
| 06/30/1998 | US5773527 Non-crosslinked, polybranched polymers |
| 06/30/1998 | US5773522 Polymer-bound camptothecin derivatives |
| 06/30/1998 | US5773473 Creatine supplement |
| 06/30/1998 | US5773431 Administration of a 27-hydroxycholesterol or prodrug thereof as an anti-cancer agent |
| 06/30/1998 | US5773422 Avermectin formulation |
| 06/30/1998 | US5773260 Ribozyme compositions and expression vectors |
| 06/30/1998 | US5773031 Acetaminophen sustained-release formulation |
| 06/30/1998 | US5773029 High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base |
| 06/30/1998 | US5773028 Adhesives of glucosyloxyalkyl (meth)acrylate copolymers |
| 06/30/1998 | US5773026 Aqueous formulations of water-insoluble therapeutic agent comprising carotenoids and/or tocopherols |
| 06/30/1998 | US5773025 Sustained release heterodisperse hydrogel systems--amorphous drugs |
| 06/30/1998 | US5773024 Liposomes |
| 06/30/1998 | US5773023 Enhanced skin penetration system for improving topical delivery of drugs |
| 06/30/1998 | US5773019 Inner core containing an effective amount of a low solubility agent covered by a non-bioerodible polymer coating layer that is permeable to the low solubility agent |
| 06/30/1998 | US5773007 Vaccine compositions |
| 06/30/1998 | US5773003 Can be administered to a mammal to elicit antihapten antibodies that are capable of binding and neutralizing hapten at site of entry into body |
| 06/30/1998 | US5773001 Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| 06/30/1998 | US5772997 Monoclonal antibodies directed to the HER2 receptor |
| 06/30/1998 | US5772984 Forming microbubbles of gases in carriers |
| 06/30/1998 | CA2094084C Aqueous gel vehicles for retinoids |
| 06/30/1998 | CA2027930C Polymer complexes of a sugar response type |
| 06/25/1998 | WO1998027151A1 Polymer film compositions for capsules |
| 06/25/1998 | WO1998027107A1 Method of coupling polysaccharides to proteins |
| 06/25/1998 | WO1998026803A1 Pharmaceutical composition for oral administration |
| 06/25/1998 | WO1998026797A1 Wound healing formulations containing human plasma fibronectin |
| 06/25/1998 | WO1998026788A1 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation |
| 06/25/1998 | WO1998026765A1 Stabilized pharmaceutical compositions and process for the preparation thereof |
| 06/25/1998 | WO1998026764A1 Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance |
| 06/25/1998 | WO1998011887A3 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 06/25/1998 | WO1998010750A3 Nucleic acid particle delivery |
| 06/25/1998 | WO1998007449A3 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect |
| 06/25/1998 | WO1998006438A3 Composition for pharmaceutical applications |
| 06/25/1998 | WO1998003552A3 A multivalent major histocompatibility complex peptide fusion protein for modulating specific t cell function |
| 06/25/1998 | CA2275475A1 Pharmaceutical composition for oral administration |
| 06/25/1998 | CA2275193A1 Method of producing concentrated non-buffered solutions of fibronectin |
| 06/25/1998 | CA2209862A1 Acylated cyclodextrin-containing pharmaceutical composition |
| 06/24/1998 | EP0848948A1 Long-lasting composition for rectal administration |
| 06/24/1998 | EP0848913A2 Use of carotenoid solubisate for colouring foodstuffs and pharmaceutical preparations |
| 06/24/1998 | EP0848621A1 Wound treatment composition |
| 06/24/1998 | EP0848614A1 Isolation of microdomains of caveolae and gpi-anchored proteins |
| 06/24/1998 | EP0848608A2 Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
| 06/24/1998 | EP0848607A1 Pharmaceutical compositions and devices for their administration |
| 06/24/1998 | CN1185744A Stabilized compositions of fluorinated amphiphiles as contrast agents for ultrasound |
| 06/24/1998 | CN1185741A Skin permeation enhancer compositions using acyl lactylates |
| 06/24/1998 | CN1185740A Chlamydia vaccines |
| 06/24/1998 | CN1185735A Sorbic-acid-containing hydrogels |
| 06/24/1998 | CN1185716A Insecticidal composition effective against fleas on mammals particularly cats and dogs |
| 06/24/1998 | CN1185433A Carotenoid preparation capable of mixing with liquid and oil |
| 06/24/1998 | CN1185317A 丁丙诺啡经皮吸收剂 Buprenorphine percutaneous absorption |
| 06/24/1998 | CN1038842C Structured copolymers used as absorbent gels and carriers of metal ions |
| 06/24/1998 | CA2193941A1 Use of moieties for binding to hyaluronan and icam-1 |
| 06/23/1998 | US5770731 Improvements relating to prodrugs |
| 06/23/1998 | US5770710 Reacting methyltrithio antibiotic ll-e32288 derivative with mercaptan compound |
| 06/23/1998 | US5770704 Receptor activation with inactive hepatocyte growth factor ligands |
| 06/23/1998 | US5770700 Liquid factor IX formulations |
| 06/23/1998 | US5770645 Polymers for delivering nitric oxide in vivo |
| 06/23/1998 | US5770627 Sustained release |
| 06/23/1998 | US5770618 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom |
| 06/23/1998 | US5770609 Administering tamoxifen derivatives to inhibit smooth muscle cell proliferation associated with vascular trauma from surgery or transplantation of organs or medical devices |
| 06/23/1998 | US5770607 Aqueous liquid composition for external use |
| 06/23/1998 | US5770606 Administering apomorphine |
| 06/23/1998 | US5770596 Pharmaceutical compositions based on mequitazine |
| 06/23/1998 | US5770580 Somatic gene therapy to cells associated with fluid spaces |
| 06/23/1998 | US5770577 BDNF and NT-3 polypeptides selectively linked to polyethylene glycol |
| 06/23/1998 | US5770572 Methods and compositions using molecular decoyants for ameliorating the undesired effects of foreign agents which bind to endogenous receptors |
| 06/23/1998 | US5770570 Method of delivering a vasoactive intestinal polypeptide, an encapsulated vasoactive intestinal polypeptide, and a method of making the encapsulated vasoactive intestinal polypeptide |
| 06/23/1998 | US5770559 Promoting the inhalation drug delivery by forming solid particles from a slurries comprising a complexes of active drug with amphiphilic material |
| 06/23/1998 | US5770231 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles 1,2-benzisothiazoles |
| 06/23/1998 | US5770230 Method for preparing stabilized prostaglandin E1 |
| 06/23/1998 | US5770229 Medical polymer gel |
| 06/23/1998 | US5770228 Platelet derived growth factor gel formulation |
| 06/23/1998 | US5770222 Therapeutic drug delivery systems |
| 06/23/1998 | US5770195 Antitumor |
| 06/23/1998 | US5770181 Useful for magnetic resonance imaging and tomogrphy; consists of perfluorocarbon contrast agent, bicarbonate gas generating agent, flavor enhancing agent, a drug and a bioactive agent |
| 06/23/1998 | US5769787 Medical scanning and treatment system and method |